NASDAQ:XAIR
Beyond Air, Inc. Stock News
$1.37
-0.0150 (-1.08%)
At Close: May 17, 2024
Beyond Air® Announces Participation at Two Upcoming Investor Conferences in March 2023
07:00am, Wednesday, 22'nd Feb 2023
GARDEN CITY, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on
Beyond Air, Inc. (XAIR) Q3 2023 Earnings Call Transcript
08:29pm, Thursday, 09'th Feb 2023
Beyond Air, Inc. (NASDAQ:XAIR ) Q3 2023 Earnings Conference Call February 9, 2023 4:30 PM ET Company Participants Edward Barger - Head, Investor Relations Steve Lisi - Chairman and CEO Duncan Fatkin -
Beyond Air, Inc. (XAIR) Reports Q3 Loss, Lags Revenue Estimates
06:50pm, Thursday, 09'th Feb 2023
Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -2.38% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Beyond Air® Schedules Third Fiscal Quarter 2023 Financial Results Conference Call and Webcast
04:05pm, Tuesday, 17'th Jan 2023
Call scheduled for Thursday, February 9th at 4:30 pm Eastern Time Call scheduled for Thursday, February 9th at 4:30 pm Eastern Time
Beyond Air, Inc. (XAIR) Q2 2023 Results - Earnings Call Transcript
02:38am, Wednesday, 09'th Nov 2022
Beyond Air, Inc. (NASDAQ:XAIR ) Q2 2023 Results Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Edward Barger - Head of Investor Relations Steve Lisi - Chairman and Chief Exe
Beyond Air® Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast
04:05pm, Thursday, 20'th Oct 2022
Call scheduled for Tuesday, November 8ᵗʰ at 4:30 pm Eastern Time Call scheduled for Tuesday, November 8ᵗʰ at 4:30 pm Eastern Time
Beyond Cancer™ to Present Pre-Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2022 SITC Annual Meeting
08:00am, Wednesday, 05'th Oct 2022
Abstract titles to be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting were released publicly today at 8:00 AM EDT Abstract titles to be presented at the Society for Immunoth
Beyond Air® To Participate in Three Upcoming Investor Conferences
04:05pm, Friday, 16'th Sep 2022
GARDEN CITY, N.Y., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment
Beyond Air, Inc. (XAIR) CEO Steve Lisi on Q1 2023 Results - Earnings Call Transcript
11:05pm, Thursday, 11'th Aug 2022
Beyond Air, Inc. (NASDAQ:XAIR ) Q1 2023 Results Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Corey Davis - Investor Relations, LifeSci Advisors Steve Lisi - Chairman and Ch
Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast
08:05pm, Wednesday, 27'th Jul 2022 GlobeNewswire Inc.
Call scheduled for Thursday, August 11th at 4:30 pm Eastern Time Call scheduled for Thursday, August 11th at 4:30 pm Eastern Time
Coinbase, Moderna And 56 Biggest Movers From Yesterday
08:42am, Thursday, 07'th Jul 2022 Benzinga
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-ti
Why Is DoorDash Down By 8%? 38 Stocks Moving In Wednesday's Mid-Day Session
04:08pm, Wednesday, 06'th Jul 2022 Benzinga
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time chang
H.B. Fuller And 2 Other Stocks Insiders Are Buying
11:33am, Wednesday, 06'th Jul 2022 Benzinga
Although the Nasdaq Composite jumped 1.75% on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they vie
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
08:55am, Thursday, 30'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offerin
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
04:32pm, Wednesday, 29'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
Brickell Biotech, Inc. (NASD